Dallas, TX 2/24/2011 12:12:31 AM
News / Stocks

NUBL, ITKH, CBIS are included in our Top Penny Stock Gainers

NUBL, ITKH, CBIS are some of today’s top penny stock gainers.

NuMobile, Inc. (OTCBB: NUBL) reached up 100% in morning trading to $.0004 with 53M shares traded. NuMobile is building a portfolio of security and software solutions for the global mobile computing and smartphone market. Through a roll-up strategy, NuMobile plans to acquire and develop mobile computing solutions for a variety of applications, including mobile banking, for the global marketplace. NuMobile, Inc. (OTC.BB:NUBL - News) today announced that the Company remained listed on the Regulation SHO "threshold security" list as of February 22, 2011 (link:http://www.nasdaqtrader.com/trader.aspx?id=RegSHOThreshold). Management anticipates a possible buy-in that could result in an increased share price.

iTeknik Holding Corporation (PINK: ITKH) reached up 23.33% in morning trading to $.0037 with 4M shares traded. iTeknik Holding Corporation provides wholesale and retail telecommunications services, and products worldwide. Its services include voice over Internet protocol origination and termination; A-Z routing and switching; wholesale carrier routing services; reseller billing and reporting; Web-based reseller solutions; prepaid calling card solutions; international cellular calling; and retail point of sale solutions. The company serves B2B carriers, telecom resellers, retail outlets and consumers direct through websites such as www.greatminutes.com and www.indiaminutes.com. iTeknik Holding Corporation (Pinksheets:ITKH - News) announced yesterday afternoon that it has retained its Pink Sheets "Current Information" designation through 3Q FY 2011. The Current Information Update along with an updated Attorney Opinion letter has been accepted by Pink OTC Market's Issuer Services.

Cannabis Science, Inc. (OTCBB: CBIS) reached up 95.44% in morning trading to $.1329 with 19M shares traded. Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. Cannabis Science, Inc. (OTCBB:CBIS.ob - News) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana derivative) products, is pleased to announce that numerous patients are reporting that Cannabis Science extract treatments are killing cancer cells. Cannabis Science, in conjunction with Rockbrook, its Colorado-licensed dispensary, consulted with a variety of cancer patients who were seeking to inform themselves of the current peer reviewed scientific literature, regarding the historical use of cannabis to treat "tumors”. Unlike most conventional cancer treatments, cannabis has an outstanding safety profile, and patients in states with medical marijuana laws are able to make an informed decision to legally try various cannabis preparations to determine what is most effective for their particular condition.

For a detailed quote on any of the following companies, or to read the full news articles visit PennyTrader.com

About PennyTrader.com

PennyTrader.com is a financial and investor relations website committed to covering the microcap market space including Pink Sheets and OTC Bulletin Board and sub-$5 big board stocks. We strive to provide you with the best stocks alerts in the market! We focus on OTCBB, OTC, penny stocks, sub-$5 big board stocks, and timely stocks picks and alerts. Our goal is to inform you of the HOTTEST stocks in the market before they move. Our staff has years experience in the stock market, and we are confident that you’ll be impressed with the results of our stock picks! If you wish to feature your organization on our website then you can contact us at publisher@pennytrader.com.

Disclosure: PennyTrader.com is not currently being compensated for any stocks covered in this midday report

PennyTrader.com is not a registered investment advisers or broker/dealer. PennyTrader.com makes no recommendation that the purchase of securities of companies profiled in this press release is suitable or advisable for any person or that an investment such securities will be profitable. In general, given the nature of the micro cap companies covered and the potential lack of an active trading market their securities, investing in such securities is highly speculative and carries a high degree of risk. For our full disclaimer go to CLICK HERE